Form 4: Performant Healthcare Director Eric Yanagi Reports RSU Grant and Significant Indirect Holdings

Performant Healthcare Director Eric Yanagi reported the acquisition of 35,616 restricted stock units as compensation and disclosed significant indirect beneficial ownership of 3,261,675 common shares through an affiliated fund.

Summary

• Eric Yanagi, a Director of Performant Healthcare Inc. (PFMT), reported a transaction on July 28, 2025.
• He acquired 35,616 shares of common stock, $0.0001 par value, at a price of $0.
• These shares represent Restricted Stock Units (RSUs) granted as compensation for his board service.
• The RSUs will vest on the earlier of the issuer's 2026 annual meeting of stockholders or a change of control.
• Mr. Yanagi's direct beneficial ownership after the transaction is 381,835 shares.
• His indirect beneficial ownership is 3,261,675 shares, held by Mill Road Capital II, L.P.
• Mr. Yanagi disclaims direct pecuniary interest in the newly acquired RSU shares, as Mill Road Capital Management, LLC has the right to their economic benefit.
• He also disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest, as he controls the voting and disposal through his role at Mill Road Capital II GP LLC.

Sentiment

Score: 6

Explanation: The filing is largely neutral as it reports a routine compensation event for a director. The grant of RSUs is a positive for aligning interests, but the disclaimer of direct pecuniary interest for these specific shares slightly tempers the direct personal financial alignment, though significant indirect holdings remain.

Positives

• The acquisition of Restricted Stock Units (RSUs) as compensation aligns the director's interests with the long-term performance and shareholder value of Performant Healthcare Inc.
• The significant indirect beneficial ownership of 3,261,675 shares by an affiliated fund, over which the director has control, indicates a substantial vested interest in the company's success.

Negatives

• The reporting person disclaims direct pecuniary interest in the newly acquired 35,616 RSU shares, as an affiliate (Mill Road Capital Management, LLC) has the right to receive their economic benefit, which could be perceived as a slight dilution of direct personal financial alignment for these specific shares.

Future Outlook

The acquired Restricted Stock Units are set to vest on the earlier of Performant Healthcare Inc.'s 2026 annual meeting of stockholders or a change of control, indicating a future milestone for the director's equity compensation.

Industry Context

This filing represents a routine insider transaction, specifically the grant of equity compensation to a director, which is a common practice across industries to align management and board interests with shareholder value. It does not provide broader industry-specific insights or trends.

Corporate Governance

Related Party Transactions

• Mill Road Capital Management, LLC, an affiliate of the Reporting Person, has the right to receive the economic benefit of the 35,616 acquired Restricted Stock Units, leading Mr. Yanagi to disclaim direct pecuniary interest in these specific shares.
• 3,261,675 shares are indirectly held by Mill Road Capital II, L.P. (the 'Fund'), where Mr. Yanagi, through his role as a management committee director of Mill Road Capital II GP LLC (the sole general partner of the Fund), has sole authority to vote and dispose of these shares on behalf of the Fund.

Stakeholder Impact

• Shareholders: The grant of equity compensation to a director generally aligns the director's interests with long-term shareholder value. The transparency of significant indirect holdings through an affiliated fund provides clarity on the director's overall exposure to the company's performance.

Next Steps

• The Restricted Stock Units (RSUs) granted to Eric Yanagi are scheduled to vest on the earlier of Performant Healthcare Inc.'s 2026 annual meeting of stockholders or a change of control.

Key Dates

Recommendation

This Form 4 filing primarily details a routine grant of Restricted Stock Units (RSUs) as compensation to a director and clarifies existing indirect beneficial ownership. It does not contain new information that would significantly alter the investment thesis for Performant Healthcare Inc. The RSU grant aligns the director's interests with long-term shareholder value, which is a positive, but it's a standard compensation practice. The significant indirect holdings through Mill Road Capital are already known or expected for a director associated with such a fund. Therefore, the filing supports a 'hold' recommendation, as it provides no new catalysts for a 'buy' or 'sell' decision.

Keywords

Performant Healthcare, PFMT, Eric Yanagi, Director, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Compensation, Beneficial Ownership, Mill Road Capital